Research Grade Lifastuzumab(DHB65401) Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Research Grade Lifastuzumab(DHB65401) Usage And Synthesis

Uses

Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity[1].

References

[1] Banerjee S, et al. Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29(4):917-923. DOI:10.1093/annonc/mdy023

Research Grade Lifastuzumab(DHB65401)(1615697-16-9)Related Product Information

• Vapaliximab
• Actoxumab
• Drozitumab
• Tiragolumab
• Tilvestamab
• Elezanumab
• Odronextamab
• Dalotuzumab
• Gemtuzumab
• Zilovertamab